N—01 / Oral Microbiome Program
Active research · 2026
Norphem · Clinical Oral Microbiome Research

Clinical care for the conditions medicine overlooked.

We start with the oral microbiome. We won’t stop there.

/ 01 · Founded by
20+ yrs

Practicing otolaryngology behind every formulation decision.

/ 02 · Approach
Microbiome.

Built around the environment chronic oral conditions actually live in.

/ 03 · Manufacturing
cGMP / USA

Third-party tested for purity, potency, and contaminants.

/ 04 · Pipeline
N—01live

One formulation shipped. The next overlooked condition is in research.

What we saw
N—Section / 02

There is a gap between “use mouthwash” and “remove your tonsils.” Millions live in it.

For most chronic oral conditions, modern care offers a frustrating split. Either the problem isn’t “serious enough” to treat — or the only intervention is invasive.

Recurring tonsil stones are the clearest example. They are not life-threatening, so ENTs decline surgery. They are not caused by poor hygiene, so dentists have nothing more to recommend.

People are left with cotton swabs, salt water, and the same condition rebuilding week after week — for years, sometimes decades.

Norphem was founded to close that gap. Not with bigger promises. With deeper science.

The gap0products

existed to address the actual mechanism — biofilm, anaerobes, and microbiome imbalance — in a single daily formulation. So one was built.

“Use mouthwash.” — or — “Remove your tonsils.”

Between those two answers is where most people with recurring tonsil stones spend years of their lives. Norphem starts there.

Our method
N—Section / 03

We work on the environment, not the symptom.

Most oral care attacks what you can see — the smell, the stone, the surface. Norphem starts deeper. We formulate around the microbial environments where chronic oral conditions actually live: biofilm structures, anaerobic colonies, salivary defense systems, microbiome balance.

Removing what has already formed is not the same as resetting what creates it. Every Norphem formulation is designed against the same principle: change the environment, change the cycle.

01 / Pillar

Root-Cause Formulation

02 / Pillar

Clinical-Grade Actives

03 / Pillar

Essential by Design

Unique mechanism

Four steps. One cycle, broken.

Every Norphem formulation moves through the same sequence: dismantle what’s already there, target what feeds it, rebalance the environment, and support the system that keeps it balanced. CryptReset+ is the first product built on this protocol.

01
Step 01

Break

02
Step 02

Target

03
Step 03

Rebalance

04
Step 04

Support

N—01 / In Market · First FormulationFull product page
N—01 / In Market 30 lozenges · Vanilla mint
Our first formulation

CryptReset+

A daily slow-dissolving lozenge built for the hidden crypt cycle behind recurring tonsil stones.

  • Helps break the biofilm-like barrier inside tonsil crypts
  • Targets the anaerobic bacteria linked to recurring buildup
  • Supports a rebalanced oral microbiome with K12, M18, and L. reuteri

Built around a four-step mechanism — Break · Target · Rebalance · Support — CryptReset+ is the first formulation in the Norphem line. One slow-dissolving lozenge a day. No scraping. No rinsing routine. No starting over every week.

See how CryptReset+ works
Our story

After 20+ years in ENT, our founder built the formula he could never prescribe.

Dr. Vogel spent more than two decades as an otolaryngologist. In that time, thousands of patients came through his practice with the same complaint: the white lumps, the foul taste, the constant fear of being too close to anyone.

He had two options to offer them.

A tonsillectomy — invasive, weeks of recovery, and rarely justified by insurance for a condition considered this “minor.” Or the same advice every other ENT was giving: gargle with salt water, improve oral hygiene, learn to live with it. He saw the look on patients’ faces when he delivered that second option. He delivered it for years.

2003
2010 — 2020
2022
2026

What he found was a body of science that had quietly redrawn the picture of chronic oral conditions. The dominant clinical model — “tonsil stones are trapped debris” — was incomplete. The deeper story involved biofilm matrices, anaerobic colonization, disrupted salivary defense, and microbial imbalance specifically inside the tonsil crypts.

The same mechanisms that explained why stones kept coming back also explained why every conventional remedy fell short. There was no product on the market that addressed all of these at once. So he built one.

For twenty years I told patients there was nothing more I could do. The science said otherwise. I just had to be willing to read it.
Dr. Vogel, Founder of Norphem

CryptReset+ is the formulation he wishes he could have handed to every patient who walked out of his office without an answer. Norphem is the company built to take that approach — clinical, microbiome-first, root-cause — into every overlooked condition that comes next.

We are not a supplement brand that happens to make a tonsil-stone product. We are a clinical research project that began with one.

How we formulate

Every active ingredient has to earn its place.

Norphem formulations are built from a short list of clinically studied compounds, each selected for a defined mechanism. We don’t hide doses inside proprietary blends. We don’t include trending ingredients without a functional reason. We don’t formulate for the label — we formulate for the result.

/ 01 · Research

Oral Microbiome Research

/ 02 · Manufacturing

Third-Party Manufactured

/ 03 · Transparency

Transparent Formulation

What’s not in our products

A short, sober list.

The same discipline we apply to what we put in — applied to what we leave out. No exceptions, no “clean” loopholes.

N—Section / 08
  • / 01No artificial colors, flavors, or preservatives
  • / 02No titanium dioxide
  • / 03No added sugar
  • / 04No alcohol
  • / 05Non-GMOVeganGluten-freeDairy-free
  • / 06Manufactured in the USA, in cGMP-certified facilities
What’s next

Tonsil stones are the first overlooked condition we addressed. They are not the last.

The same approach that produced CryptReset+ — clinical research, microbiome-first formulation, root-cause focus — is being applied to a pipeline of conditions modern care continues to ignore. We’ll announce them when the science is ready, not before.

N—01Released

CryptReset+

A daily slow-dissolving lozenge for the hidden crypt cycle behind recurring tonsil stones.

Recurring tonsil stones · In market
N—02In research
Name · TBA

An overlooked oral-microbiome condition. Mechanism identified.

A second formulation already in research. Same approach as CryptReset+: mechanism-first, microbiome-aware, root-cause.

Oral microbiome · Discovery
N—03Concept
Name · TBA

Adjacent ENT condition, same root-cause framework.

A related ENT-adjacent condition our founder treated for decades. Early-stage concept work on the same clinical framework.

ENT · Concept
N—04Backlog
Name · TBA

Patient-submitted complaint pattern, awaiting science.

A pattern reported by patients of the original practice. Mechanism not yet defined; the science is being reviewed.

Patient-reported · Backlog
Norphem · Est. 2026
Norphem.

Clinical care for the conditions medicine overlooked.

N—01 / Oral Microbiome